$26.21 -0.85 (-3.14%)
11/27/2009 1:00 PM

Masimo Corp (MASI)

CAPS Rating: 4 out of 5

A global medical technology company that develops, manufactures and markets non-invasive patient monitoring products that improve patient care.

Results 1 - 18 of 18

Recs

0
Member Avatar jge54515 (< 20) Submitted: 5/28/2009 5:14:46 PM : Outperform Start Price: $22.81 MASI Score: -6.20

non-invasive hgb monitoring is going to be hot

Recs

0
Member Avatar golfer121501 (93.76) Submitted: 11/25/2008 11:06:30 AM : Outperform Start Price: $24.25 MASI Score: -24.61

Screener test

Recs

0
Member Avatar scrubs620 (41.88) Submitted: 5/15/2008 1:15:26 AM : Outperform Start Price: $35.00 MASI Score: -5.60

got FDA approval for a hemoglobin monitoring technology

Up on 6x normal volume

Recs

1
Member Avatar bravato (37.47) Submitted: 4/30/2008 2:20:52 PM : Outperform Start Price: $29.49 MASI Score: +7.86

Guys and gals, this is the kind of tip you're looking for:
My mother is the EMS coordinator for the Bay Area/Northern California fire and medical departments, and she is doing a revolutionary study on the long term effects of Carbon Monoxide on firefighter's respitory systems.
She has concluded, over a period of five plus years of intense research, that firefighters (especially forestry divisions) do not adequately protect against Carbon Monoxide, and the effects on the body are much worse than those from cigarettes.
Here's where MASIMO comes into play. . . She is working concurrently with Masimo, developing an on-site Carbon Monoxide monitoring device, to be used on firefighters on the scene of fires. If they show dangerous levels, they are to be put on Oxygen, which reverses the adverse effects of carbon monoxide.
She is working on a statewide/national bill that would REQUIRE ALL FIRE STATIONS TO USE THIS PRODUCT. Every single fire station in America will be using Masimo non invasive monitoring devices, thanks to my mother's hard work. . . you can thank us later :)

Recs

0
Member Avatar momlehane (< 20) Submitted: 3/24/2008 12:01:39 PM : Outperform Start Price: $27.58 MASI Score: +10.92

Massimo blood gas analyzers do something that the competition does not - it works with existing equipment AND it can function by itself as a new purchase. The strides that Masi has made in monitoring CO in the blood for Emergency Techs to use in the field has an incredible edge in initiating appropriate care in a timely manner.

Recs

0
Member Avatar Nathansstocks (< 20) Submitted: 1/1/2008 12:04:59 PM : Outperform Start Price: $39.50 MASI Score: -11.57

Right area, right time. With Boomers begining to retire this sector will outperform for the next several years...and this stock in particular is positioned for growth which will out pace the sector.

Recs

0
Member Avatar anthonysdaddy (84.04) Submitted: 12/7/2007 4:05:05 PM : Outperform Start Price: $38.30 MASI Score: -8.33

Masimo is the only manufacturer of a monitor that reads carboxi hemoglobin. That determines the levels of CO in your blood. That allows emergency medical providers to determine if you have CO poisoning without doing an arterial blood gas in the hospital. Speeding up treatment

Recs

0
Member Avatar eleyan (< 20) Submitted: 11/20/2007 11:54:45 AM : Outperform Start Price: $31.00 MASI Score: +5.28

They seem to have a very innovative solution in in measuring CO2 levels in the blood. I see in the news that some hospitals are already switching to their products. If it turns out to be a big hit and becomes a must have for every hospital then the stock will shoot up.

Recs

0
Member Avatar lessismore2007 (83.80) Submitted: 11/12/2007 3:57:28 PM : Outperform Start Price: $30.20 MASI Score: +8.15

As the largest demographic group in our country's history (baby boomers) grows older each day and begins to succumb to the ills of their fast food and high stress lifestyles, medical devices that improve patient care, are truly innovative, and developed by well run companies will do well. Very Well! The older we get, the more we fear death, the more we complain, the more we vote and demand Washington do something about our plight i.e. health care in the next 5-20 years.

Recs

0
Member Avatar mjoyce19 (85.82) Submitted: 11/10/2007 11:00:26 AM : Outperform Start Price: $29.88 MASI Score: +8.66

Its stock price continues to increase due to its gain in market share and prospects for the future. Also, there are talks about emerging technology that they have patented and are developing which can come to fruition within the next few years.

Recs

0
Member Avatar rudivail (< 20) Submitted: 11/2/2007 2:47:49 PM : Outperform Start Price: $31.30 MASI Score: +7.17

they make a great product, that every hospital will use over and over again.

Recs

0
Member Avatar BBLOCKER68 (< 20) Submitted: 10/24/2007 3:52:40 PM : Outperform Start Price: $31.87 MASI Score: +6.41

Revenue and earnings are projected to rise 25% this fiscal year. The company has always been on the rise since it's inception.

Recs

0
Member Avatar epimetavalent (< 20) Submitted: 10/19/2007 6:35:47 PM : Outperform Start Price: $29.88 MASI Score: +10.60

pure speculation.

Recs

0
Member Avatar fast1x2 (51.73) Submitted: 10/19/2007 4:50:53 PM : Outperform Start Price: $29.88 MASI Score: +10.60

Measures oxygen levels in real time, used mostly in surgical setting.

Recs

0
Member Avatar tdonb (62.73) Submitted: 10/8/2007 11:20:58 AM : Outperform Start Price: $31.01 MASI Score: +10.47

my speculative pick

Recs

0
Member Avatar Lawrence56 (< 20) Submitted: 10/6/2007 1:12:57 PM : Outperform Start Price: $31.60 MASI Score: +9.07

Under-followed IPO recommended by J C

Recs

0
Member Avatar fb32257 (< 20) Submitted: 9/13/2007 8:11:06 PM : Outperform Start Price: $24.93 MASI Score: +27.18

excellent technology

Recs

2
Member Avatar tenmiles (99.99) Submitted: 9/10/2007 1:54:06 PM : Underperform Start Price: $24.10 MASI Score: -29.33

This is an interesting small cap involved in non-invasive monitoring - several "name" hospitals are early adopters ... but at $24.25 with a $1.1b market cap, current stock price appears rich, both on a fundamental and technical basis in the intermediate term (IPO was around $17). Seller here, looking for buying oppt. back in the teens.

Results 1 - 18 of 18

Featured Broker Partners